Generate a tailored SOP for Dr. Konstantinos Konstantopoulos. Improve your application with a focused, well-structured draft.
Konstantinos Konstantopoulos is the inaugural William H. Schwarz Professor in the Department of Chemical and Biomolecular Engineering. His research focuses on the intersection of engineering, biology, and medicine, particularly in the context of cancer metastasis. The Konstantopoulos group investigates how vascular tissue microenvironments influence the dissemination of cancer cells from primary tumors to distant organs, with the ultimate goal of developing innovative diagnostic and prognostic tools to predict cancer progression and patient outcomes. His lab utilizes a multidisciplinary approach to design therapeutic strategies aimed at combating cancer metastasis. Konstantopoulos has pioneered the identification and biophysical characterization of adhesion molecules that preferentially express in tumor cells, facilitating their metastatic spread. His lab has created the Microfluidic Invasion Network Device (MIND), which aims to improve the prediction of metastatic potential in patients, thereby preventing overtreatment with ineffective therapies. He has held various leadership roles, including Chair of the Department of Chemical and Biomolecular Engineering from 2008 to 2017, and has led numerous NIH-supported projects. Recognized for his contributions to the field, Konstantopoulos has been elected a Fellow of the American Institute for Medical and Biological Engineering and has received several awards for his teaching and research efforts.
Johns Hopkins University • Baltimore, MD
Inaugural William H. Schwarz Professor and researcher in the field of chemical and biomolecular engineering with a focus on cancer metastasis.
Department of Pathology - PhD in Pathobiology. GRE is not required.